日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab's Place in COVID-19 Pneumonia

系统评价和亚组荟萃分析随机试验,以确定托珠单抗在 COVID-19 肺炎中的地位

Klopfenstein, Timothée; Gendrin, Vincent; Gerazime, Aurélie; Conrozier, Thierry; Balblanc, Jean-Charles; Royer, Pierre-Yves; Lohse, Anne; Mezher, Chaouki; Toko, Lynda; Guillochon, Cerise; Badie, Julio; Pierron, Alix; Kadiane-Oussou, N 'dri Juliette; Puyraveau, Marc; Zayet, Souheil

Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)

接受托珠单抗治疗的2019冠状病毒病(COVID-19)相关急性呼吸窘迫综合征患者死亡率的预测因素

Lohse, Anne; Klopfenstein, Timothée; Balblanc, Jean-Charles; Royer, Pierre-Yves; Bossert, Marie; Gendrin, Vincent; Charpentier, Aline; Bozgan, Ana-Maria; Badie, Julio; Bourgoin, Charlotte; Contreras, Remy; Mazurier, Isabelle; Conrozier, Thierry; Zayet, Souheil

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study

评估缓释他喷他多联合按需速释他喷他多治疗严重慢性骨关节炎相关膝关节疼痛的有效性和安全性:一项开放标签的3b期研究结果

Steigerwald, Ilona; Müller, Matthias; Kujawa, Jolanta; Balblanc, Jean-Charles; Calvo-Alén, Jaime

Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures

接受抗肿瘤坏死因子α治疗的类风湿性关节炎患者的手术:一项对50例手术的观察性研究

Wendling, D; Balblanc, J-C; Brousse, A; Lohse, A; Lehuede, G; Garbuio, P; Toussirot, E; Auge, B; Jacques, D